Cargando…

Cytomegalovirus Hemorrhagic Cystitis in a Malignant Glioma Patient Treated with Temozolomide

Temozolomide, a key drug in the treatment of malignant glioma, can cause profound lymphopenia and various opportunistic infectious diseases. A 79-year-old woman with anaplastic oligodendroglioma developed a fever and gross hematuria after 8 weeks of standard radiotherapy with concomitant temozolomid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Furukawa, Ryutaro, Homma, Hirokuni, Inoue, Tomohiro, Horiuchi, Hajime, Usui, Kazuhiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6232021/ https://www.ncbi.nlm.nih.gov/pubmed/29780148 http://dx.doi.org/10.2169/internalmedicine.1005-18

Ejemplares similares

Good's syndrome with clinical manifestation after thymectomy: A case report
por: Furukawa, Ryutaro, et al.
Publicado: (2018)

Temozolomide in malignant glioma
por: Dresemann, Gregor
Publicado: (2010)

Treating malignant glioma in Chinese patients: update on temozolomide
por: Chang, Liang, et al.
Publicado: (2014)

Temozolomide Chemotherapy in Patients with Recurrent Malignant Gliomas
por: Yang, Seung-Ho, et al.
Publicado: (2006)

The strategy for enhancing temozolomide against malignant glioma
por: Nakada, Mitsutoshi, et al.
Publicado: (2012)

Cytomegalovirus haemorrhagic cystitis in a pregnant patient with AIDS
por: Marais, Bernard, et al.
Publicado: (2023)

Hyperbaric oxygen–A new horizon in treating cyclophosphamide-induced hemorrhagic cystitis
por: Ajith Kumar, S, et al.
Publicado: (2011)

Impact of Temozolomide on Immune Response during Malignant Glioma Chemotherapy
por: Sengupta, Sadhak, et al.
Publicado: (2012)

Efficacy and Safety of Temozolomide Combined with Radiotherapy in the Treatment of Malignant Glioma
por: Wei, Shoufeng, et al.
Publicado: (2022)

Hemorrhagic Cystitis due to BK Reactivation in a Young Female Treated for Hodgkin-Disease
por: Le Calloch, R., et al.
Publicado: (2011)

Endovascular Management of Radiation-Induced Hemorrhagic Cystitis
por: Gowda, Ganesh G, et al.
Publicado: (2019)

Xanthogranulomatous Cystitis Treated by Transurethral Resection
por: Yamamoto, Sachi, et al.
Publicado: (2015)

Recurrent hemorrhagic shock from hemorrhagic cystitis due to neurogenic bladder
por: Isobe, Teruki, et al.
Publicado: (2021)

Inhibition of telomerase activity in malignant glioma cells correlates with their sensitivity to temozolomide
por: Kanzawa, T, et al.
Publicado: (2003)

Antitumor effect of fibrin glue containing temozolomide against malignant glioma
por: Anai, Shigeo, et al.
Publicado: (2014)

Toxicity Profile of Temozolomide in the Treatment of 300 Malignant Glioma Patients in Korea
por: Bae, So Hyun, et al.
Publicado: (2014)

Retracted: Efficacy and Safety of Temozolomide Combined with Radiotherapy in the Treatment of Malignant Glioma
por: Engineering, Journal of Healthcare
Publicado: (2023)

EXPLORING THE ROLE OF GAT1 AND GABA IN TEMOZOLOMIDE TREATED GLIOMA
por: Poole, Alisha, et al.
Publicado: (2023)

The Successful Treatment of Pulmonary Pleomorphic Carcinoma with Pembrolizumab: A Case Report
por: Matsumoto, Yoko, et al.
Publicado: (2017)

Small-Cell Carcinoma Transformation of Pulmonary Adenocarcinoma after Osimertinib Treatment: A Case Report
por: Taniguchi, Yuri, et al.
Publicado: (2018)

Brain metastasis effectively treated with erlotinib following the acquisition of resistance to gefitinib: a case report
por: Ohara, Sayaka, et al.
Publicado: (2014)

Recurrence of herpes simplex encephalitis associated with temozolomide chemoradiation for malignant glioma: a case report and review of the literature
por: Christman, Mitalee P., et al.
Publicado: (2014)

A rapid and systematic review of the effectiveness of temozolomide for the treatment of recurrent malignant glioma
por: Dinnes, J, et al.
Publicado: (2002)

KCa3.1 channel inhibition sensitizes malignant gliomas to temozolomide treatment
por: D'Alessandro, Giuseppina, et al.
Publicado: (2016)

Phase I study of low-dose metronomic temozolomide for recurrent malignant gliomas
por: Wong, Eric T., et al.
Publicado: (2016)

COT-06 HBV REACTIVATION DURING AND AFTER THE TREATMENT OF MALIGNANT GLIOMA WITH TEMOZOLOMIDE
por: Kanamori, Masayuki, et al.
Publicado: (2019)

Hemorrhagic Cystitis in a Patient Receiving Docetaxel for Prostate Cancer
por: Ntekim, A.I., et al.
Publicado: (2010)

Hemorrhagic cystitis: A challenge to the urologist
por: Manikandan, R., et al.
Publicado: (2010)

Penicillin G-induced hemorrhagic cystitis
por: Kaya, Engin, et al.
Publicado: (2015)

Dabigatran Induced Hemorrhagic Cystitis in a Patient with Painful Bladder Syndrome
por: Otteno, Helen, et al.
Publicado: (2014)

Hemorrhagic Cystitis in a Liver Transplant Recipient Secondary to BK Virus
por: Kamal, Faisal, et al.
Publicado: (2017)

β-arrestin 1 Overexpression Increases Temozolomide Resistance in Human Malignant Glioma Cells
por: ARTENE, S.A., et al.
Publicado: (2017)

Effectiveness of interferon-beta and temozolomide combination therapy against temozolomide-refractory recurrent anaplastic astrocytoma
por: Fujimaki, Takamitsu, et al.
Publicado: (2007)

Response of Leptomeningeal Dissemination of Anaplastic Glioma to Temozolomide: Experience of Two Cases
por: Bae, Jin Woo, et al.
Publicado: (2017)

Evolving evidence implicates cytomegalovirus as a promoter of malignant glioma pathogenesis
por: Cobbs, Charles S
Publicado: (2011)

Human Cytomegalovirus Antigens in Malignant Gliomas as Targets for Adoptive Cellular Therapy
por: Landi, Daniel, et al.
Publicado: (2014)

Treatment of Severe Refractory Hematuria due to Radiation-Induced Hemorrhagic Cystitis with Dexamethasone
por: Nascimento, José Carlos Rodrigues, et al.
Publicado: (2017)

Propyl Gallate Exerts an Antimigration Effect on Temozolomide-Treated Malignant Glioma Cells through Inhibition of ROS and the NF-κB Pathway
por: Yang, Jen-Tsung, et al.
Publicado: (2017)

Low c-Met expression levels are prognostic for and predict the benefits of temozolomide chemotherapy in malignant gliomas
por: Li, Ming-Yang, et al.
Publicado: (2016)

MicroRNA-93 promotes the malignant phenotypes of human glioma cells and induces their chemoresistance to temozolomide
por: Chen, Rui, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_tdehnkpem9l2is9r9rvpjdgsv4